Batchvarova, M., Shan, S., Zennadi, R., Lindgren, M., Leitgeb, A., Tamsen, P. S., & Telen, M. J. (2013). Sevuparin Reduces Adhesion Of Both Sickle Red Cells and Leukocytes To Endothelial Cells In Vitro and Inhibits Vaso-Occlusion In Vivo. In Blood (Vol. 122, pp. 182–182). American Society of Hematology. https://doi.org/10.1182/blood.v122.21.182.182

Batchvarova, Milena, Siqing Shan, Rahima Zennadi, Maria Lindgren, Anna Leitgeb, Pirkko Sulila Tamsen, and Marilyn J. Telen. “Sevuparin Reduces Adhesion Of Both Sickle Red Cells and Leukocytes To Endothelial Cells In Vitro and Inhibits Vaso-Occlusion In Vivo.” In Blood, 122:182–182. American Society of Hematology, 2013. https://doi.org/10.1182/blood.v122.21.182.182.

Batchvarova M, Shan S, Zennadi R, Lindgren M, Leitgeb A, Tamsen PS, et al. Sevuparin Reduces Adhesion Of Both Sickle Red Cells and Leukocytes To Endothelial Cells In Vitro and Inhibits Vaso-Occlusion In Vivo. In: Blood. American Society of Hematology; 2013. p. 182–182.

Batchvarova, Milena, et al. “Sevuparin Reduces Adhesion Of Both Sickle Red Cells and Leukocytes To Endothelial Cells In Vitro and Inhibits Vaso-Occlusion In Vivo.” Blood, vol. 122, no. 21, American Society of Hematology, 2013, pp. 182–182. Crossref, doi:10.1182/blood.v122.21.182.182.

Batchvarova M, Shan S, Zennadi R, Lindgren M, Leitgeb A, Tamsen PS, Telen MJ. Sevuparin Reduces Adhesion Of Both Sickle Red Cells and Leukocytes To Endothelial Cells In Vitro and Inhibits Vaso-Occlusion In Vivo. Blood. American Society of Hematology; 2013. p. 182–182.